ecancermedicalscience

Review

A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus

25 Jan 2018
Danielle Crawley, Florence Chamberlain, Hans Garmo, Sarah Rudman, Björn Zethelius, Lars Holmberg, Jan Adolfsson, Par Stattin, Paul Carroll, Mieke Van Hemelrijck

Prostate cancer (PCa) and type two diabetes mellitus (T2DM) are both increasing prevalent conditions and often occur concurrently. However, the relationship between the two is more complex than just two prevalent conditions co-existing. This review systematically explores the literature around the interplay between the two conditions. It covers the impact of pre-existing T2DM on PCa incidence, grade and stage, as well as exploring the impact of T2DM on PCa outcomes and mortality and the interaction between T2DM and PCa treatments.

Related Articles

Tushar Ambekar, Amey Oak, Sivaranjini Kannusamy, Sandhya Cheulkar, Riya R John, Shalmali Chavan, Saket Mendhe, Supriya Kadam, Mamta Lade, Ganesh Balasubramanium, Ashwin Desouza, Avanish Saklani, Rajesh Dikshit, Pankaj Chaturvedi, Sudeep Gupta
Joshua Agilinko, Sonam Patel, Jogitha Selvarajah, Nicholas Tekkis, Mathew Vithayathil, Suzette Samlalsingh
Viviana Pinzón-Ramírez, Luis E Cueva-Cañola, Dilmareth E Natera, Helder Edgar Aldo-Chávez Olivera, Oscar Eduardo Camacho-Hernández, Andrea C Beltran-De la Fuente, Sergio Alexis Ramirez-Alvarez, Einstein Yhair Gallardo Cubas, Giomar Vilca Flores, Mauricio E Gamez, Leonardo Rangel Castilla
Kevin Guzmán, Vanessa Pabón, Andrés Angulo, Luis E Bravo, Arsenio Hidalgo, Carol Rosero, Alvaro Pazos